Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

SuperGen has the Highest Future Earnings Growth in the Biotechnology Industry (SUPG, DUSA, GHDX)
Financial News Network
Saturday, December 31, 2011 - 12:51pm
tags:
Supergen
The Zacks Analyst Blog Highlights: Teva Pharmaceuticals, Mylan, Watson Pharma, Dr. Reddy's and Novartis
Sacramento Bee, CA
Saturday, December 31, 2011 - 12:48pm
tags:
Teva Pharmaceuticals, Mylan, Watson Pharmaceuticals, Dr Reddy's, Novartis, generics
Teva Pharmaceutical Releases Generic Version of HIV Drug in U.S.
BusinessWeek
Saturday, December 31, 2011 - 12:45pm
tags:
Teva Pharmaceuticals, HIV, Combivir, generics, GSK
Lipitor And Strategic Collapse At Pfizer
Seeking Alpha
Saturday, December 31, 2011 - 12:38pm
tags:
Lipitor, Pfizer
FDA clears Pfizer vaccine for adults over 50
Yahoo/AP
Saturday, December 31, 2011 - 12:37pm
tags:
Pfizer, Prevnar 13, vaccines, pneumococcal disease, pneumonia
The Worst Health-Care Stocks of 2011 (video)
Motley Fool
Saturday, December 31, 2011 - 12:34pm
tags:
A Bad Year for the 6,300% Miracle (Human Genome Sciences)
Motley Fool
Saturday, December 31, 2011 - 12:33pm
tags:
Human Genome Sciences, Benlysta, lupus, GSK
Is Amgen a Buffett Stock?
Motley Fool
Friday, December 30, 2011 - 1:28pm
tags:
Amgen, Warren Buffett
Alnylam, Medtronic RNAi drug-device combo wows with preclinical data
Fierce Drug Delivery
Friday, December 30, 2011 - 11:36am
tags:
Alnylam, Medtronic, Device, RNAi
United Therapeutics Passes This Key Test
Motley Fool
Friday, December 30, 2011 - 11:35am
tags:
United Therapeutics
Missouri CRO fined for falsifying clinical trial work for Boehringer
Fierce Biotech
Friday, December 30, 2011 - 9:19am
tags:
Missouri, CROs, Boehringer Ingelheim, clinical trials, PPS Clinical Research
India's Lupin gets US approval for fenofibrate tablets
Reuters
Friday, December 30, 2011 - 9:18am
tags:
Lupin, India, FDA, fenofibrate, generics, Abbott Laboratories, TriCor
Teva Heads to Biggest Drop Since 2006 on New Competition: Israel Overnight
Bloomberg
Friday, December 30, 2011 - 9:13am
tags:
Teva Pharmaceuticals, morning-after pill, Copaxone
Amgen: Xgeva panel review scheduled for February
Yahoo/AP
Thursday, December 29, 2011 - 10:35pm
tags:
Amgen, Xgeva, advisory panel, FDA, prostate cancer
What to Look For With Seattle Genetics in 2012
Motley Fool
Thursday, December 29, 2011 - 10:34pm
tags:
Seattle Genetics, Adcetris
What to Look For From Keryx and Aeterna Zentaris in 2012
Motley Fool
Thursday, December 29, 2011 - 10:32pm
tags:
Keryx, Aeterna Zentaris, colon cancer, perifosine
Peregrine Provides Update on HCV Clinical Program
Yahoo
Thursday, December 29, 2011 - 10:30pm
tags:
HCV, Peregrine Pharmaceuticals, bavituximab
Is 2012 Make or Break for Cell Therapeutics?
Motley Fool
Thursday, December 29, 2011 - 10:28pm
tags:
Cell Therapeutics, pixantrone
Why Profitable Pfizer Won't Fall Off The Patent Cliff Anytime Soon
Seeking Alpha
Thursday, December 29, 2011 - 10:17pm
tags:
Pfizer, patents, patent cliff
Biotech Stocks At A Critical Juncture
Investopedia.com
Thursday, December 29, 2011 - 1:32pm
tags:
Jazz Pharmaceuticals, Oncothyreon, Questcor, Indenix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.